OTCMKTS:RHHBY Roche (RHHBY) Stock Price, News & Analysis $40.66 +0.15 (+0.37%) As of 04/29/2025 03:59 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartDividendHeadlinesInsider TradesOwnershipShort InterestBuy This Stock About Roche Stock (OTCMKTS:RHHBY) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Roche alerts:Sign Up Key Stats Today's Range$40.60▼$41.0950-Day Range$35.90▼$44.2452-Week Range$29.20▼$44.31Volume3.24 million shsAverage Volume3.08 million shsMarket Capitalization$259.33 billionP/E RatioN/ADividend Yield2.09%Price TargetN/AConsensus RatingHold Company OverviewRoche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It is also developing products for various therapeutic areas. In addition, it offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases; diagnostic instruments; and digital health solutions. Roche Holding AG was founded in 1896 and is based in Basel, Switzerland.Read More… Receive RHHBY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Roche and its competitors with MarketBeat's FREE daily newsletter. Email Address RHHBY Stock News Headlines3 Top Big Pharma Stocks Investing Over $100 Billion in the U.S. (RHHBY)See these three top-10 stocks in the pharmaceutical industry that are pledging investment in the United States totalling over $100 billion.April 28 at 7:28 AM | marketbeat.comBlood-Based Biomarkers (BBB) Market Review 2023-2024 and Growth Opportunities 2025-2035 Featuring Profiles of Key Players - Roche, Sysmex Corporation, MiRXES, Minomic, Creative Diagnostics and MoreApril 30 at 7:04 AM | globenewswire.comThe Worst Year in American Financial History?Economist Explains: The Curse on the U.S. Dollar Yes, there is a Curse on the U.S. Dollar... and it's behind all the chaos you've seen play out in the global economy in 2025. This curse has nothing to do with astrology or anything metaphorical. In fact, it's studied at the highest levels of finance and academia ... and VP Vance even questioned Jerome Powell about it. It's a wild money story you could soon hear everywhere. Only one investigative journalist is telling the story here.April 30, 2025 | Stansberry Research (Ad)CHMP recommends EU label update for Roche’s Phesgo to allow administration outside of clinical settingsApril 30 at 2:19 AM | finance.yahoo.comCHMP recommends EU label update for Roche's Phesgo to allow administration outside of clinical settingsApril 30 at 1:00 AM | globenewswire.comNotable healthcare headlines for the week: Merck, Roche and Bausch Health in focusApril 27 at 5:35 PM | msn.comRoche price target lowered to CHF 286 from CHF 312 at Morgan StanleyApril 26, 2025 | markets.businessinsider.comRoche: Key Products Stall, Obesity Pipeline Takes ShapeApril 25, 2025 | seekingalpha.comSee More Headlines RHHBY Stock Analysis - Frequently Asked Questions How have RHHBY shares performed this year? Roche's stock was trading at $34.88 on January 1st, 2025. Since then, RHHBY stock has increased by 16.6% and is now trading at $40.66. View the best growth stocks for 2025 here. Does Roche have any subsidiaries? Roche subsidiaries include these companies: Inflazome, Stratos Genomics, Promedior, Spark Therapeutics, Tusk Therapeutics, Flatiron Health, Ignyta, and more. Who are Roche's major shareholders? Roche's top institutional investors include GAMMA Investing LLC (0.01%), Boston Common Asset Management LLC (0.01%), OLD National Bancorp IN and Altrius Capital Management Inc. How do I buy shares of Roche? Shares of RHHBY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Today4/30/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Pharmaceutical preparations Sub-IndustryPersonal Services Current SymbolOTCMKTS:RHHBY CIKN/A Webwww.roche.com Phone(161) 688-1111Fax41-0-61-691-9391Employees103,605Year Founded1896Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E Ratio14.47 P/E Growth2.18Net IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio0.86 Current Ratio1.26 Quick Ratio0.97 Sales & Book Value Annual Sales$68.73 billion Price / Sales3.77 Cash Flow$3.17 per share Price / Cash Flow12.82 Book Value$5.81 per share Price / Book7.00Miscellaneous Outstanding Shares6,377,936,000Free FloatN/AMarket Cap$259.33 billion OptionableNot Optionable Beta0.48 Social Links Reduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.Get This Free Report This page (OTCMKTS:RHHBY) was last updated on 4/30/2025 by MarketBeat.com Staff From Our PartnersM.A.G.A. is Finished – This Could be even BetterYou’ve no doubt heard Trump’s rally cry: Make America Great Again. But recently the President made a big ch...Paradigm Press | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredMusk's warning signal: Prepare before the cascade beginsWhen Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t...InvestorPlace | SponsoredThe collapse has already startedThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Roche Holding AG Please log in to your account or sign up in order to add this asset to your watchlist. Share Roche With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.